Suppr超能文献

古巴晚期非小细胞肺癌患者 EORTC QLQ-C30 问卷的潜在维度。

Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer.

机构信息

Center of Molecular Immunology (CIM), Havana, Cuba.

University of Havana, Havana, Cuba.

出版信息

Qual Life Res. 2020 Dec;29(12):3441-3448. doi: 10.1007/s11136-020-02584-5. Epub 2020 Nov 2.

Abstract

BACKGROUND

Quality of Life Core Questionnaire of the European Organization for the Research and Treatment of Cancer (EORTC QLQ-C30) is one of the most used quality of life questionnaires in cancer studies. It provides scores for five functional scales, nine symptom scales, and two single items which assess overall health status and quality of life. However, high correlations among QLQ-C30 items suggest a reduced dimensionality for the scale.

OBJECTIVE

To assess the dimensionality of the EORTC QLQ-C30 using item response theory (IRT) in a training sample and confirmatory factor analysis (CFA) in a test sample.

METHODS

We analyzed responses to QLQ-C30 from 1,107 patients with advanced lung cancer who were included in five clinical trials of immunotherapy. We used non-parametric and parametric IRT models (Mokken, and Samejima's graded response) in a random training set (n = 332) for initial assessment of dimensions and item characteristics of the QLQ-C30. Finally, we used CFA in the test set (n = 775) to confirm the measurement domains.

RESULTS

Mokken model showed that QLQ-C30 fits a unidimensional scale, whereas Samejima model showed that most QLQ-C30 items present adequate difficulty and discrimination. All items showed adequate scalability indexes with an overall scalability of 0.47 (medium scale). The QLQ-C30-reduced dimensionality was confirmed by CFA (comparative fit index = 0.98, root mean square error of approximation = 0.055) with all items presenting factorial loadings > 0.40.

CONCLUSIONS

The EORTC QLQ-C30 fits a unidimensional latent construct identified with perceived quality of life in advanced lung cancer patients.

TRIAL REGISTRATION

RPCEC00000161, RPCEC00000181 and RPCEC00000205.

摘要

背景

欧洲癌症研究与治疗组织(EORTC)生命质量核心问卷(QLQ-C30)是癌症研究中使用最广泛的生命质量问卷之一。它提供了五个功能量表、九个症状量表和两个单项的评分,用于评估总体健康状况和生命质量。然而,QLQ-C30 项目之间的高度相关性表明该量表的维度减少。

目的

使用项目反应理论(IRT)在训练样本中评估 EORTC QLQ-C30 的维度,并在测试样本中使用验证性因子分析(CFA)进行验证。

方法

我们分析了来自 5 项免疫治疗临床试验的 1107 例晚期肺癌患者对 QLQ-C30 的反应。我们在随机训练集(n=332)中使用非参数和参数 IRT 模型(Mokken 和 Samejima 的渐进反应)对维度和 QLQ-C30 项目特征进行初步评估。最后,我们在测试集(n=775)中使用 CFA 对测量领域进行验证。

结果

Mokken 模型显示 QLQ-C30 适合单维量表,而 Samejima 模型显示大多数 QLQ-C30 项目具有足够的难度和区分度。所有项目的可扩展性指标均足够,总可扩展性为 0.47(中等规模)。CFA 验证了 QLQ-C30 的降维(拟合优度指数=0.98,近似均方根误差=0.055),所有项目的因子负荷均大于 0.40。

结论

EORTC QLQ-C30 适合于识别晚期肺癌患者感知生命质量的单一潜在结构。

试验注册

RPCEC00000161、RPCEC00000181 和 RPCEC00000205。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验